datalabs-logo

  • Ask Datalabs
  • My Feed
  • Companies
  • Investors
  • People
  • Funding Rounds
  • Acquisitions

  • Research Reports
  • Industries
  • Locations
Immunito AI-logo
Immunito AI
Immunito AI-logoImmunito AI-logo
Immunito AI

Immunito AI - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Private
IMMUNITOAI PRIVATE LIMITED
Private
IMMUNITOAI PRIVATE LIMITED
2020
2020

Founded in 2020, Immunito AI operates in Health Tech industry. Initially focusing on leveraging AI to streamline the antibody discovery process, the company has evolved to enhance the efficiency and e...

Funding stage:

Series A

Last funding:

24/11/2025

Total funding:

$7.10 Mn+

Revenue:

₹5.8 Lakh+ (FY25)

Investors

Employee count:

25

Last 90d

25

Last 90d

Web traffic:

522

522

Last 30d

Last 30d

Glassdoor Rating:

Immunito AI: Financial Breakdown

Decoding financial health metrics of Immunito AI

  • total_revenue_logo
    Total Revenue
    ₹2.2 Lakh
  • total_expenses_logo
    Total Expenses
    ₹1.9 Cr
    1587%

    Prev. FY

  • profit_after_tax_logo
    Profit After Tax
    ₹-1.9 Cr
    -1566%

    Prev. FY

  • total_assets_logo
    Total Assets
    ₹1.6 Cr
    365%

    Prev. FY

  • net_profit_margin_logo
    Net Profit Margin
    -87.5%
Note: Above mentioned stats are for FY21-22

FAQs on Financials of Immunito AI

No. In FY25, Immunito AI reported a net loss of ₹1.2 Cr, so it was not profitable.

Immunito AI's revenue declined 87.0% year-on-year, from ₹44.9 Lakh in FY24 to ₹5.8 Lakh in FY25.

In FY25, Immunito AI posted revenue of ₹5.8 Lakh (down 87.0% YoY) and a net loss of ₹1.2 Cr. Explore the full financials of Immunito AI here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

MY FEEDDISCOVERRESEARCH